The flu season is off to an early and strong start. Flu activity has been reported as widespread in at least 46 states, including Indiana. Riley Hospital for Children at IU Health is currently restricting visitors to protect patients and prevent further spreading. Learn more.
The Precision Genomics Program at Riley at IU Health helps children with all types of relapsed or aggressive cancer receive personalized treatment. Our innovative approach to care can help reveal new treatment options that may be effective when other treatment options no longer work.
The precision genomics team uses genetic testing to identify DNA, RNA and proteins in cancer cells that can be precisely targeted with different treatments. Based on test results, the team then recommends treatment options that are specific to your child’s needs. These targeted therapies may also have fewer side effects than previous treatments, helping your child have a better quality of life.
The Precision Genomics Program is the only program of its kind in Indiana to offer this comprehensive, personalized medicine service. We provide each step of care, from biopsy of cancer cells to testing to evaluation and treatment. Our multidisciplinary team includes a pediatric physician, nurse coordinator, pharmacist, molecular geneticist and social worker. The team also works closely with other physicians, scientists and pediatric bioethicists at Riley at IU Health.
Your child's oncologist may refer your child to the Precision Genomics Program if he or she may benefit from our services. After we review your child’s health information, we will quickly send tumor cells that were previously biopsied (surgically removed) for specialized testing.
You will meet with our entire team while we wait for the test results to learn more about the program and what we look for in your child's tumor cells. We will help you understand what to expect as you move forward with the next step in your child’s cancer treatment and will take the time to get to know your family.
After we receive your child’s test results, we will work with your child’s oncologist and other Riley at IU Health experts to explore the treatment options best suited to your child’s particular form of cancer. We share these recommendations with your family, helping you understand your options so you can make informed decisions about your child’s care. You will then work with your child’s oncologist to move forward with the new treatments that you choose.
When we make recommendations for your child’s care, we strive to take into account your family’s preferences about how and where your child receives his or her treatment.
Our pediatric specialists provide patient- and family-centered care for most related conditions. The links below provide more specific information about some, but not all, of the conditions that we treat.
Doctors with the Precision Genomics Program offer personalized cancer treatment for children.
The Precision Genomics Program at Riley at IU Health provides the following forms for parents, healthcare providers and personnel.
Patient Referral for Precision Genomics Program
We provide multispecialty care for a number of conditions. Below are links to our related departments.
Learn more about the Precision Genomics Program. To refer a patient to the Precision Genomics Program, please call 317.274.7308. Families may also self-refer patients.
The Precision Genomics Program is a fully integrated clinical research program, helping children receive advanced, evidence-based care. Our providers are involved in research projects, including long-term studies of the benefits of precision genomics, new ways to treat relapsed cancer and techniques for identifying aggressive cancer. Research efforts, combined with fellowship training of pediatric oncologists, allow us to shape the future of pediatric cancer care.
The precision genomics team at Riley at IU Health helps train the next generation of pediatric oncologists. Pediatric oncology/hematology fellows at the Indiana University School of Medicine learn about the latest advancements in personalized cancer treatment by spending part of their training with our team.